Registered Nurse in Cabo Rojo, PR Accepting Medicare
5 Registered Nurse nurses found. Showing 1 - 5
 Mrs. Mirza Acosta, RN Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: Carr 103 Km 9 Hm 9 Buzon481, Cabo Rojo, PR 00623 Phone: 787-264-9588 Fax: 787-849-0912 |
Mrs. Stephanie Martinez, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 114c Callejon Los Martinez, Cabo Rojo, PR 00623 Phone: 787-292-9605 |
 Sven Joel Cabassa Caban, Registered Nurse - Gerontology Medicare: Not Enrolled in Medicare Practice Location: Calle 20 Parcela Elizabeth Iii #646, Cabo Rojo, PR 00623 Phone: 787-373-3249 |
Mrs. Frances Marie Colom, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: E36 Calle Pedro Flores, Urb. Borinquen, Cabo Rojo, PR 00623 Phone: 787-462-8022 |
Mr. Carlos Eduardo Antonio Ruiz Lugo Sr., ENFERMERO RN, WCS Registered Nurse - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 80 Cabo Rojo, Urb Mansiones De Cabo Rojo Palmas, Cabo Rojo, PR 00623 Phone: 787-398-2164 Fax: 787-255-1846 |
News Archive
Tolerx enters collaborative research agreement with Cancer Research Institute
Tolerx, Inc., a biopharmaceutical company developing novel therapies by modulating T cell activity, and the Cancer Vaccine Acceleration Fund (CVAF) a nonprofit program of the Cancer Research Institute established in partnership with the Ludwig Institute for Cancer Research today announced they entered into a collaborative research agreement to support development of Tolerx's drug candidate, TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
Ugandan President calls for public-private partnership to fight HIV/AIDS during U.S. meeting
Ugandan President Yoweri Museveni last week during a meeting in Washington, D.C., with representatives from the African Diplomatic Corps, U.S. government officials and representatives from the health care industry called for a public-private partnership to fight HIV/AIDS in Uganda, Uganda's Monitor reports.
Chemotherapy delivered directly into liver blood vessels increases progression-free survival in melanoma patients
Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).
Genomas awarded $1.2 million to develop DNA-guided system for management of statin therapy
Genomas, a biomedical company advancing DNA-guided medicine and personalized healthcare, has announced the award of a Fast-Track Phase I-II Small Business Innovation Research (SBIR) Grant totaling $1.2 million.
› Verified 8 days ago